China’s Venus Buys Israeli Heart-Valve Maker: Xinhua

Chinese heart disease treatment company Venus Medtech has acquired the Israeli company Cardiovalve for $300 million, both companies said according to Xinhua.

Founded in 2009 and headquartered in the eastern city of Hangzhou, Venus Medtech is a leader in transcatheter heart valvular therapies in China.

Read the full report: Xinhua.

SEE MORE:

Asia tech firms turn to making medical gear

Chinese medical data firm LinkDoc drops plan for US listing

China sets up medical device, chips innovation centres

George Russell

George Russell is a freelance writer and editor based in Hong Kong who has lived in Asia since 1996. His work has been published in the Financial Times, The Wall Street Journal, Bloomberg, New York Post, Variety, Forbes and the South China Morning Post.

You Might also Like

Germany to Ban China Purchase of Medical Group - Handelsblatt

CSRC Approves 3 Stocks for Shenzhen Growth Board - Xinhua